Related Experiment Video
Updated: Aug 6, 2026
10:47
Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells (NPCs)
Published on: March 2, 2018
APCDD1 shows high specificity for ventral midbrain dopaminergic progenitors in a cell surface marker benchmarking
Alrik L Schörling1,2, Alison Salvador1, Pedro Rifes1
1Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW), Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
NPJ Parkinson'S Disease
|July 20, 2026
Summary
APCDD1 is a novel cell surface marker that precisely identifies dopaminergic progenitors for Parkinson's disease (PD) treatment. This marker improves cell quality control and enrichment, leading to better therapeutic outcomes.
Area of Science:
- Neuroscience
- Cell Biology
- Regenerative Medicine
Background:
- Cell surface markers are crucial for quality control and enrichment of specific cell types.
- Accurate regional specificity of markers is often unknown, limiting their clinical application.
- Dopaminergic (DA) progenitors are key for Parkinson's disease (PD) treatment.
Purpose of the Study:
- To identify and validate a novel cell surface marker with high regional specificity for caudal ventral midbrain DA progenitors.
- To assess the efficacy of this marker for improving cell enrichment and quality control in PD therapeutics.
Main Methods:
- Flow cytometry analysis was used to compare the specificity of APCDD1 with seven other markers.
- Antibody-based cell sorting was employed to enrich DA progenitors using APCDD1.
- Functional assessment involved grafting sorted cells into a rat model of PD.
Main Results:
- APCDD1 demonstrated superior regional selectivity for caudal ventral midbrain DA fate compared to existing markers.
- APCDD1-based sorting successfully enriched DA progenitors and depleted non-DA populations.
- Grafting of APCDD1-high cells into PD rat models led to significant motor function improvement and a higher proportion of ventral midbrain DA neurons.
Conclusions:
- APCDD1 is a highly specific surface marker for caudal ventral midbrain DA progenitors.
- APCDD1 offers a promising tool for enhancing the quality control and enrichment of cell products for PD treatment.
- This marker has the potential to improve the efficacy of cell-based therapies for Parkinson's disease.
